Richard Levy
Radiation Oncology · Scottsdale, AZNPI 1811245533
Payments from drug & device makers
Across 105 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$366
- GSK$299
- Sanofi$197
- Novartis$150
- Lilly USA, LLC$143
- Merck$138
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $366 |
| GSK | 7 | $299 |
| Sanofi | 4 | $197 |
| Novartis | 7 | $150 |
| Lilly USA, LLC | 9 | $143 |
| Merck | 7 | $138 |
| Blue Earth Diagnostics | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $103 |
| Bayer | 6 | $97 |
| Gilead | 1 | $83 |
| Varian Medical Systems, Inc. | 1 | $59 |
| Tactile Systems Technology Inc | 2 | $57 |
| Pharmacosmos Therapeutics Inc. | 2 | $56 |
| AbbVie | 2 | $54 |
| Myovant Sciences Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Seagen Inc. | 2 | $48 |
| Incyte Corporation | 2 | $47 |
| Pfizer | 2 | $45 |
| EMD Serono, Inc. | 2 | $43 |
| Progenics Pharmaceuticals, Inc. | 2 | $42 |
| Amgen | 2 | $37 |
| AVEO Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca | 2 | $34 |
| Karyopharm Therapeutics Inc. | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Bristol Myers Squibb | 1 | $30 |
| Accuray Incorporated | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| Adaptive Biotechnologies Corporation | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Novocure Inc. | 1 | $24 |
| Menarini Silicon Biosystems, Inc. | 1 | $23 |
| Beigene USA, Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,660 in reported general payments places this provider in the 55th percentile of 138 radiation oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 13 | $339 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Scottsdale
- Chi ZhangScottsdale$495K
- Terence SioScottsdale$221K
- Carlos VargasScottsdale$179K
- Aaron AmbradScottsdale$30K
- Vershalee ShuklaScottsdale$19K
- Gordon GradoScottsdale$12K
- Gregory MaggassScottsdale$11K
- Scott TannehillScottsdale$8K
- Randa TaoScottsdale$6K
- Apar GuptaScottsdale$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.